Literature DB >> 16186853

Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis.

Leslie T Cooper1, Kenton J Zehr.   

Abstract

BACKGROUND: A previously healthy 47-year-old woman presented reporting nausea, anorexia and light-headedness of 2 weeks' duration, and three episodes of syncope. She also had pleuritic chest pain and rapidly declining cardiac function. The only reported medical history was urinary tract infection and an ankle fracture sustained 5 months before presentation. She was receiving no medication other than estrogen patches for menopause and did not smoke or use illicit drugs. INVESTIGATIONS: Electrocardiography, chest radiography, echocardiography, measurement of creatinine phosphokinase and troponin T, coronary angiography and endomyocardial biopsy. DIAGNOSIS: Necrotizing eosinophilic myocarditis. MANAGEMENT: Biventricular assist device implantation, methylprednisolone, prednisolone and mycophenolate mofetil.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186853     DOI: 10.1038/ncpcardio0322

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  13 in total

1.  An autopsy case of necrotizing eosinophilic myocarditis causing left ventricular wall rupture.

Authors:  Kleio Fragkouli; Antigoni Mitselou; Vassiliki Boumba; Labros Michalis; Theodore Vougiouklakis
Journal:  Forensic Sci Med Pathol       Date:  2011-04-24       Impact factor: 2.007

2.  Necrotizing eosinophilic myocarditis.

Authors:  Martin Janík; Petr Hejna
Journal:  Forensic Sci Med Pathol       Date:  2017-03-07       Impact factor: 2.007

3.  Fast spontaneous recovery from acute necrotizing eosinophilic myopericarditis without need for immunosuppressive therapy: a case report of a 27-year-old male.

Authors:  Michael Kindermann; Nitin Sood; Peter Ehrlich; Karin Klingel
Journal:  Eur Heart J Case Rep       Date:  2020-06-17

4.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

Review 5.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

6.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.

Authors:  Veena Taneja; Marshall Behrens; Leslie T Cooper; Satsuki Yamada; Hirohito Kita; Margret M Redfield; Andre Terzic; Chella David
Journal:  J Mol Cell Cardiol       Date:  2007-03-27       Impact factor: 5.000

7.  Acute eosinophilic myocarditis mimicking myocardial infarction.

Authors:  Senthil K Thambidorai; Hema L Korlakunta; Amy J Arouni; William J Hunter; Mark J Holmberg
Journal:  Tex Heart Inst J       Date:  2009

Review 8.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

9.  Significance of troponin I level as a marker of disease activity in the management of acute necrotizing eosinophilic myocarditis with normal peripheral eosinophil count: a case report.

Authors:  Takamori Kakino; Hirotake Yokoyama; Kenichi Eshima
Journal:  Eur Heart J Case Rep       Date:  2018-11-26

10.  Eosinophilic myocarditis: two case reports and review of the literature.

Authors:  Jacques Rizkallah; Angela Desautels; Amrit Malik; Shelley Zieroth; Davinder Jassal; Farrukh Hussain; Francisco Cordova
Journal:  BMC Res Notes       Date:  2013-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.